IS7061A - Tvívetnis N-setnir og a-setnir dífenýlalkoxý ediksýru amínó alkýl esterar og lyf sem innihalda téð efnasambönd - Google Patents
Tvívetnis N-setnir og a-setnir dífenýlalkoxý ediksýru amínó alkýl esterar og lyf sem innihalda téð efnasamböndInfo
- Publication number
- IS7061A IS7061A IS7061A IS7061A IS7061A IS 7061 A IS7061 A IS 7061A IS 7061 A IS7061 A IS 7061A IS 7061 A IS7061 A IS 7061A IS 7061 A IS7061 A IS 7061A
- Authority
- IS
- Iceland
- Prior art keywords
- substituted
- diphenylalkoxy
- dihydrogen
- compounds
- acetic acid
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/40—Oxygen atoms
- C07D211/44—Oxygen atoms attached in position 4
- C07D211/46—Oxygen atoms attached in position 4 having a hydrogen atom as the second substituent in position 4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/10—Drugs for disorders of the urinary system of the bladder
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B59/00—Introduction of isotopes of elements into organic compounds ; Labelled organic compounds per se
- C07B59/002—Heterocyclic compounds
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
- Y10T436/00—Chemistry: analytical and immunological testing
- Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
- Y10T436/145555—Hetero-N
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Urology & Nephrology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Hydrogenated Pyridines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10129832A DE10129832A1 (de) | 2001-06-17 | 2001-06-17 | Deuterierte N- und alpha-substituierte Diphenylalkoxyessigsäureaminoalkylester sowie diese Verbindungen enthaltende Arzneimittel |
PCT/DE2002/002260 WO2002102743A2 (de) | 2001-06-17 | 2002-06-17 | Deuterierte n- und alpha-substituierte diphenylalkoyxessigsäureaminoalkylester sowie diese verbindungen enthaltende arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
IS7061A true IS7061A (is) | 2003-11-28 |
Family
ID=7688891
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IS7061A IS7061A (is) | 2001-06-17 | 2003-11-28 | Tvívetnis N-setnir og a-setnir dífenýlalkoxý ediksýru amínó alkýl esterar og lyf sem innihalda téð efnasambönd |
Country Status (16)
Country | Link |
---|---|
US (1) | US20040242887A1 (is) |
EP (1) | EP1397327A2 (is) |
JP (1) | JP2004534802A (is) |
KR (1) | KR20040020926A (is) |
CN (1) | CN1516684A (is) |
CA (1) | CA2451638A1 (is) |
CZ (1) | CZ20033365A3 (is) |
DE (1) | DE10129832A1 (is) |
HU (1) | HUP0400213A3 (is) |
IL (1) | IL159410A0 (is) |
IS (1) | IS7061A (is) |
NO (1) | NO20035599D0 (is) |
NZ (1) | NZ530352A (is) |
PL (1) | PL367218A1 (is) |
RU (1) | RU2004101229A (is) |
WO (1) | WO2002102743A2 (is) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008070619A1 (en) * | 2006-12-04 | 2008-06-12 | Auspex Pharmaceuticals, Inc. | Deuterated oxazolidinones and their use as antibiotics |
US20090209608A1 (en) * | 2007-08-29 | 2009-08-20 | Protia, Llc | Deuterium-enriched asenapine |
US20090062185A1 (en) * | 2007-08-29 | 2009-03-05 | Protia, Llc | Deuterium-enriched anidulafungin |
US20090069219A1 (en) * | 2007-09-09 | 2009-03-12 | Protia, Llc | Deuterium-enriched telavancin |
US20090076158A1 (en) * | 2007-09-13 | 2009-03-19 | Protia, Llc | Deuterium-enriched bicalutamide |
US20090075870A1 (en) * | 2007-09-17 | 2009-03-19 | Protia, Llc | Deuterium-enriched caspofungin |
US20090082419A1 (en) * | 2007-09-26 | 2009-03-26 | Protia, Llc | Deuterium-enriched tegaserod |
AR075584A1 (es) | 2009-02-27 | 2011-04-20 | Intermune Inc | COMPOSICIONES TERAPEUTICAS QUE COMPRENDEN beta-D-2'-DESOXI-2'-FLUORO-2'-C-METILCITIDINA Y UN DERIVADO DE ACIDO ISOINDOL CARBOXILICO Y SUS USOS. COMPUESTO. |
US20120244122A1 (en) * | 2009-05-28 | 2012-09-27 | Masse Craig E | Peptides for the Treatment of HCV Infections |
MX2012003171A (es) * | 2009-09-28 | 2012-04-11 | Hoffmann La Roche | Novedosos inhibidores macrociclicos de la replicacion del virus de hepatitis c. |
CN102584592B (zh) * | 2011-12-28 | 2014-10-15 | 李进 | 一种氘代的拟除虫菊酯化合物及其制备方法和应用 |
PL2810936T3 (pl) * | 2012-01-30 | 2018-04-30 | Taiho Pharmaceutical Co., Ltd. | Nowy związek estrowy kwasu octowego lub jego sól |
AU2013300009B2 (en) * | 2012-08-09 | 2017-06-15 | Chase Pharmaceuticals Corporation | Piperidinium quaternary salts |
KR101745814B1 (ko) | 2013-05-30 | 2017-06-12 | 다이호야쿠힌고교 가부시키가이샤 | 신규한 불소화 벤질산 에스테르 화합물 또는 그의 염 |
CN107445798B (zh) * | 2016-06-01 | 2020-11-03 | 中国农业大学 | 一种α,α‐二氘代醇类化合物的合成方法 |
CN116078377B (zh) * | 2023-03-06 | 2023-06-27 | 泽升科技(广州)有限公司 | 一种负载催化剂催化制备氘代苯的生产工艺 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DD106642A1 (is) * | 1973-03-02 | 1974-06-20 | ||
DD139212A1 (de) * | 1978-10-09 | 1979-12-19 | Christian Starke | Verfahren zur herstellung eines neuen arzneimittels aus alpha,alpha-diphenyl-alpha-alkoxyessigsaeure-1-methylpiperidyl-4-ester-derivaten |
JPS6439873A (en) * | 1987-08-05 | 1989-02-10 | Sharp Kk | Synchronizing signal generating circuit |
JPH08509206A (ja) * | 1993-01-28 | 1996-10-01 | ユニバーシティー オブ アイオワ リサーチ ファウンデイション | 吸入麻酔薬としての重水素化されたセボフルラン |
DE4343838C2 (de) * | 1993-12-22 | 1998-07-09 | Lohmann Therapie Syst Lts | Deuteriertes Arzneimittel in transdermaler Applikation und Verfahren zu seiner Herstellung |
-
2001
- 2001-06-17 DE DE10129832A patent/DE10129832A1/de not_active Withdrawn
-
2002
- 2002-06-17 CZ CZ20033365A patent/CZ20033365A3/cs unknown
- 2002-06-17 CN CNA028121201A patent/CN1516684A/zh active Pending
- 2002-06-17 PL PL02367218A patent/PL367218A1/xx not_active Application Discontinuation
- 2002-06-17 RU RU2004101229/04A patent/RU2004101229A/ru not_active Application Discontinuation
- 2002-06-17 WO PCT/DE2002/002260 patent/WO2002102743A2/de not_active Application Discontinuation
- 2002-06-17 EP EP02752970A patent/EP1397327A2/de not_active Withdrawn
- 2002-06-17 JP JP2003505289A patent/JP2004534802A/ja active Pending
- 2002-06-17 US US10/481,153 patent/US20040242887A1/en not_active Abandoned
- 2002-06-17 NZ NZ53035202A patent/NZ530352A/xx unknown
- 2002-06-17 HU HU0400213A patent/HUP0400213A3/hu unknown
- 2002-06-17 IL IL15941002A patent/IL159410A0/xx unknown
- 2002-06-17 KR KR10-2003-7016441A patent/KR20040020926A/ko not_active Application Discontinuation
- 2002-06-17 CA CA002451638A patent/CA2451638A1/en not_active Abandoned
-
2003
- 2003-11-28 IS IS7061A patent/IS7061A/is unknown
- 2003-12-16 NO NO20035599A patent/NO20035599D0/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
NO20035599D0 (no) | 2003-12-16 |
IL159410A0 (en) | 2004-06-01 |
HUP0400213A3 (en) | 2005-08-29 |
CZ20033365A3 (cs) | 2004-09-15 |
HUP0400213A2 (hu) | 2004-07-28 |
RU2004101229A (ru) | 2005-06-27 |
PL367218A1 (en) | 2005-02-21 |
EP1397327A2 (de) | 2004-03-17 |
WO2002102743A2 (de) | 2002-12-27 |
KR20040020926A (ko) | 2004-03-09 |
DE10129832A1 (de) | 2003-07-10 |
JP2004534802A (ja) | 2004-11-18 |
CN1516684A (zh) | 2004-07-28 |
CA2451638A1 (en) | 2002-12-27 |
NZ530352A (en) | 2004-12-24 |
WO2002102743A9 (de) | 2004-03-11 |
WO2002102743A3 (de) | 2003-03-13 |
US20040242887A1 (en) | 2004-12-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IS7061A (is) | Tvívetnis N-setnir og a-setnir dífenýlalkoxý ediksýru amínó alkýl esterar og lyf sem innihalda téð efnasambönd | |
IL158504A (en) | Anthranilic acid amides and pharmaceutical preparations thereof | |
HUP0303810A3 (en) | Carboxylic acid derivative and salt thereof and pharmaceutical compositions containing them | |
IS6254A (is) | Lyfjasamsetningar sem innihalda HMG afoxunarensímlata | |
PL369511A1 (en) | Quaternary ammonium salts of omega-aminoalkylamides of r-2-aryl-propionic acids and pharmaceutical compositions containing them | |
HUP0401936A3 (en) | Benzamide and heteroaryl carboxylic amide derivatives and pharmaceutical compositions containing them for the treatment of a p2x7 mediated disease | |
PT1207867E (pt) | Formas de administracao farmaceuticas orais retardadas contendo tramadol | |
HUP0501089A2 (en) | Therapeutic isoquinoline compounds and pharmaceutical compositions coutaining them | |
HK1064035A1 (en) | Pharmaceutical salts of 1-phenyl-3-dimethylamino-propane compounds | |
DE60212044D1 (de) | Test der bukkalen Auflösung pharmazeutisch aktiver Stoffe | |
AU2002338806A1 (en) | Pharmaceutical combinations of pde-v inhibitors and other agents | |
EE05215B1 (et) | Meetod tskloproplkarbokslhappe estrite ja derivaatide valmistamiseks | |
HRP20040067A2 (en) | Pharmaceutical compositions of amlodipine and atorvastatin | |
NO20015757D0 (no) | Felles salt av amlopidin og atorvastatin | |
IL162458A0 (en) | A stable pharmaceutical formulation of paroxetine hydrochloride anhydrous and a process for preparation thereof | |
HUP0401694A3 (en) | Crystal forms of a hydrochloride salt of a hydroxynorephedrine derivative, pharmaceutical compositions comprising thereof and use | |
IL139450A0 (en) | Methods of administering apo b-secretion/mtp inhibitors | |
HK1071133A1 (en) | Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof | |
FR2834896B1 (fr) | Composition pharmaceutique orodispersible d'ivabradine | |
HUP0303694A3 (en) | Aza-amino acid derivatives and pharmaceutical | |
IL161163A0 (en) | Anthranilic acid amides and pharmaceutical use thereof | |
AU2002233353A1 (en) | Process for the preparation of d-pantothenic acid and/or salts thereof | |
IS7246A (is) | Tvívetnis pýrasólópýrimidínon og lyf sem innihalda þessi efnasambönd | |
NO20016221D0 (no) | Difosfatsalt av et 4"-substituert-9-deokso-9A-aza-9A- homoerytromycinderivat og farmasöytisk preparat derav | |
IS7846A (is) | Aðferð til að framleiða lyfjafræðilega virkt efnasamband og til að framleiða milliefni þess |